NeuroGenetic Pharmaceuticals (United States)
- Research works
- 40 ▼ 37% vs 2013–17
- Citations
- 2.2k 54.9 per fractional work
- Top-10% rate
- 25.7% record average 16.5%
- Open access
- 40% world 28%
Not ranked overall: NeuroGenetic Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Neuroscience, 20.7×. Every wedge is a field page.
Which keywords describe research at NeuroGenetic Pharmaceuticals (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Crystal Structure, Genetic Variation, Pharmacology, Cell Signaling, Drug Discovery, Stress, Signal Transduction and Arrestin.
- Toxicology
- Distributed Systems
- Neurological Disorders
- Genetic Modification
- Biopharmaceutical Production
- Neuroinflammation
- Cytochrome P450
- Neurobiology
- Deep Learning
- Neuronal Signaling
- Schizophrenia
- Pharmacokinetics
- Alzheimer's Disease
- Reward Circuitry
- Neural Plasticity
- Serotonin
- Arrestin
- Stress
- Pharmacology
- Genetic Variation
- Crystal Structure
- Cell Signaling
- Drug Discovery
- Signal Transduction
- G-Protein-Coupled Receptors
- Prefrontal Cortex
- Dopamine
- Oxidative Stress
- Neurodegeneration
- Gene Expression
- Neurodegenerative Diseases
- Nicotinic Acetylcholine Receptors
- Genomic Integration
- Anxiety
- Metabolism
- Pharmacogenetics
- Depression
- Genetics
- Transgenic Animals
- Grid Computing
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Crystal Structure6▲ 55×2 topics
- Genetic Variation5▲ 41×4 topics
- Cell Signaling5▲ 35×3 topics
- Pharmacology5▲ 36×2 topics
- Drug Discovery5▲ 29×4 topics
- Stress4▲ 26×4 topics
- Signal Transduction4▲ 41×2 topics
- Arrestin4▲ 124×1 topic
- G-Protein-Coupled Receptors4▲ 124×1 topic
- Serotonin4▲ 150×2 topics
- Prefrontal Cortex4▲ 68×3 topics
- Neural Plasticity4▲ 46×3 topics
- Dopamine4▲ 163×1 topic
- Reward Circuitry4▲ 163×1 topic
- Oxidative Stress3▲ 4.2×15 topics
- Alzheimer's Disease2▲ 23×5 topics
- Neurodegeneration2▲ 16×6 topics
- Pharmacokinetics2▲ 17×3 topics
- Gene Expression2▲ 7.2×7 topics
- Schizophrenia2▲ 32×3 topics
- Neurodegenerative Diseases2▲ 17×4 topics
- Neuronal Signaling2▲ 135×1 topic
- Nicotinic Acetylcholine Receptors2▲ 135×1 topic
- Deep Learning1▲ 1.68×3 topics
- Genomic Integration1▲ 34×2 topics
- Neurobiology1▲ 11×5 topics
- Anxiety1▲ 9.0×5 topics
- Cytochrome P4501▲ 44×1 topic
- Metabolism1▲ 5.1×6 topics
- Neuroinflammation1▲ 12×4 topics
- Pharmacogenetics1▲ 79×1 topic
- Biopharmaceutical Production1▲ 37×2 topics
- Depression1▲ 3.8×7 topics
- Genetic Modification1▲ 69×1 topic
- Genetics1▲ 3.6×6 topics
- Neurological Disorders1▲ 3.9×10 topics
- Transgenic Animals1▲ 69×1 topic
- Distributed Systems1▲ 10×1 topic
- Grid Computing1▲ 38×1 topic
- Toxicology1▲ 12×3 topics
Which research topics does NeuroGenetic Pharmaceuticals (United States) publish most on?
By volume in 2022–2025: Neurotransmitter Receptor Influence on Behavior, Neuroethics, Human Enhancement, Biomedical Innovations, Attention Deficit Hyperactivity Disorder and Advanced Memory and Neural Computing.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Neurotransmitter Receptor Influence on Behavior Cellular and Molecular Neuroscience 0 works
- 2 Neuroethics, Human Enhancement, Biomedical Innovations Cognitive Neuroscience 0 works
- 3 Attention Deficit Hyperactivity Disorder Psychiatry and Mental health 0 works
- 4 Advanced Memory and Neural Computing Electrical and Electronic Engineering 0 works
- 5 EEG and Brain-Computer Interfaces Cognitive Neuroscience 0 works
- 6 Neural dynamics and brain function Cognitive Neuroscience 0 works
- 7 Genetics and Neurodevelopmental Disorders Genetics 0 works
- 8 Topic Modeling Artificial Intelligence 0 works
- 9 CRISPR and Genetic Engineering Molecular Biology 0 works
- 10 Machine Learning in Healthcare Artificial Intelligence 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has NeuroGenetic Pharmaceuticals (United States)'s research output changed?
Output in 2018–2022 was 37% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Rancho Santa Fe
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.